A detailed history of Tocqueville Asset Management L.P. transactions in Haemonetics Corp stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 3,925 shares of HAE stock, worth $335,312. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,925
Previous 3,925 -0.0%
Holding current value
$335,312
Previous $324,000 2.78%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$80.59 - $92.61 $27,481 - $31,580
-341 Reduced 7.99%
3,925 $335,000
Q3 2023

Nov 09, 2023

SELL
$82.56 - $93.49 $39,628 - $44,875
-480 Reduced 10.11%
4,266 $382,000
Q2 2023

Aug 11, 2023

SELL
$80.84 - $89.45 $1.03 Million - $1.13 Million
-12,681 Reduced 72.77%
4,746 $404,000
Q1 2023

May 10, 2023

SELL
$72.75 - $90.6 $452,359 - $563,350
-6,218 Reduced 26.3%
17,427 $1.44 Million
Q4 2022

Feb 09, 2023

SELL
$73.85 - $86.14 $105,974 - $123,610
-1,435 Reduced 5.72%
23,645 $1.86 Million
Q3 2022

Nov 10, 2022

SELL
$63.3 - $78.66 $9.8 Million - $12.2 Million
-154,750 Reduced 86.05%
25,080 $1.86 Million
Q1 2022

May 16, 2022

SELL
$43.77 - $63.22 $2.41 Million - $3.48 Million
-55,039 Reduced 23.43%
179,830 $11.4 Million
Q4 2021

Feb 14, 2022

BUY
$49.55 - $74.59 $2.64 Million - $3.97 Million
53,283 Added 29.34%
234,869 $12.5 Million
Q3 2021

Nov 15, 2021

SELL
$57.6 - $70.59 $346,521 - $424,669
-6,016 Reduced 3.21%
181,586 $12.8 Million
Q2 2021

Aug 16, 2021

BUY
$51.81 - $118.56 $8.48 Million - $19.4 Million
163,750 Added 686.53%
187,602 $12.5 Million
Q1 2021

May 17, 2021

SELL
$111.01 - $139.48 $134,544 - $169,049
-1,212 Reduced 4.84%
23,852 $2.65 Million
Q4 2020

Feb 16, 2021

SELL
$88.75 - $119.95 $10,561 - $14,274
-119 Reduced 0.47%
25,064 $2.98 Million
Q3 2020

Nov 16, 2020

BUY
$75.65 - $93.58 $831,015 - $1.03 Million
10,985 Added 77.37%
25,183 $2.2 Million
Q2 2020

Aug 12, 2020

BUY
$84.96 - $118.91 $1.21 Million - $1.69 Million
14,198 New
14,198 $1.27 Million
Q3 2019

Oct 31, 2019

SELL
$117.16 - $138.52 $478,364 - $565,577
-4,083 Closed
0 $0
Q2 2019

Jul 31, 2019

SELL
$81.74 - $120.34 $43,240 - $63,659
-529 Reduced 11.47%
4,083 $491,000
Q1 2019

Apr 30, 2019

SELL
$83.25 - $102.12 $17,399 - $21,343
-209 Reduced 4.34%
4,612 $403,000
Q4 2018

Feb 08, 2019

BUY
$90.66 - $116.63 $22,393 - $28,807
247 Added 5.4%
4,821 $482,000
Q3 2018

Nov 13, 2018

BUY
$89.96 - $114.58 $411,477 - $524,088
4,574 New
4,574 $524,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.38B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.